华泰联合证券有限责任公司 关于常州武进中瑞电子科技股份有限公司 2025 年度日常关联交易预计的核查意见 根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市 规则》《深圳证券交易所上市公司自律监管指引第13号——保荐业务》等有关规 定，华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐人"）作 为常州武进中瑞电子科技股份有限公司（以下简称"中瑞股份"或"公司"）首 次公开发行股票并在创业板上市的保荐人，对中瑞股份2025年度日常关联交易预 计事项进行了审慎核查，相关核查情况如下： 一、日常关联交易基本情况 （一）2025年度日常关联交易概述 中瑞股份于2025年4月23日召开第三届董事会第六次会议和第三届监事会第 五次会议，审议通过了《关于2025年度日常关联交易预计的议案》。本议案已经 公司第三届董事会第一次独立董事专门会议审议通过并发表了明确的同意意见。 | | | | | | 本年年初至 2025 年 3 月 | | | --- | --- | --- | --- | --- | --- | --- | | 关联交 | | 关联交易 | 关联交易定 | 2025 年度 | 31 ...

华泰联合证券有限责任公司 关于常州武进中瑞电子科技股份有限公司 募集资金投资项目延期的核查意见 根据《证券发行上市保荐业务管理办法》《上市公司监管指引第2号——上市 公司募集资金管理和使用的监管要求》《深圳证券交易所创业板股票上市规则》 及《深圳证券交易所上市公司自律监管指引第13号——保荐业务》等有关规定， 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐人"）作为常 州武进中瑞电子科技股份有限公司（以下简称"中瑞股份"或"公司"）首次公 开发行股票并在创业板上市的保荐人，对中瑞股份募集资金投资项目延期事项进 行了审慎核查，相关核查情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意常州武进中瑞电子科技股份有限公司 首次公开发行股票注册的批复》（证监许可〔2023〕2070号）同意注册，并经深 圳证券交易所同意，公司首次向社会公众公开发行人民币普通股（A股） 36,832,010 股 ， 每 股 发 行 价 为 人 民 币 21.73 元 ， 募 集 资 金 总 额 为 人 民 币 800,359,577.30元，扣除发行费用人民币83,091,243.59元（不含税）后，募集资金 ...

目 录 一、非经营性资金占用及其他关联资金往来情况的专项 审计说明…………………………………………………………第 1—2 页 二、非经营性资金占用及其他关联资金往来情况汇总表…………… 第 3 页 三、报告附件…………………………………………………………第 4—8 页 非经营性资金占用及其他关联资金往来情况的 专项审计说明 天健审〔2025〕15-42 号 常州武进中瑞电子科技股份有限公司全体股东： 一、对报告使用者和使用目的的限定 本报告仅供中瑞股份公司年度报告披露时使用，不得用作任何其他目的。我 们同意将本报告作为中瑞股份公司年度报告的必备文件，随同其他文件一起报送 并对外披露。 为了更好地理解中瑞股份公司 2024 年度非经营性资金占用及其他关联资金 往来情况，汇总表应当与已审的财务报表一并阅读。 二、管理层的责任 我们的责任是在实施审计工作的基础上对中瑞股份公司管理层编制的汇总 表发表专项审计意见。 中瑞股份公司管理层的责任是提供真实、合法、完整的相关资料，按照《上 市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》（证监会 公告〔2022〕26 号）和《深圳证券交易所创业板上市公司自 ...

常州武进中瑞电子科技股份有限公司 审计报告 R E P O R T 天 健 会 计 师 事 务 所 Pan -C h i n a Ce rt ifi e d Pu b l ic Acc o u n t a n ts 目 录 | 一、审计报告……………………………………………………… 第 1—6 | | 页 | | | --- | --- | --- | --- | | 二、财务报表……………………………………………………… 第 7—14 | | 页 | | | （一）合并资产负债表…………………………………………… | 第 | 页 | 7 | | （二）母公司资产负债表………………………………………… | 第 | 页 | 8 | | （三）合并利润表………………………………………………… | 第 | 页 | 9 | | （四）母公司利润表………………………………………………第 | | 页 | 10 | | （五）合并现金流量表……………………………………………第 | | 页 | 11 | | （六）母公司现金流量表…………………………………………第 | | 页 | 12 | | （七）合并所有者权益变动表…… ...

内部控制评价报告的核查意见 华泰联合证券有限责任公司 关于常州武进中瑞电子科技股份有限公司 2024 年度内部控制评价报告的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合"）作为为常州武进中瑞 电子科技股份有限公司（以下简称"中瑞股份"、"公司"）首次公开发行股票的 保荐人，根据《证券发行上市保荐业务管理办法》《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》等文件的要求，华泰联合对中 瑞股份 2024 年度内部控制制度等相关事项进行核查，并发表独立意见如下： 一、中瑞股份内部控制的基本情况 （一）内部控制环境 中瑞股份自成立以来，根据国家有关法律、法规的要求，本着规范法人治理 的原则，逐步建立健全公司内部组织机构和各项内部控制制度。 公司现设立了股东大会、董事会、监事会等相互约束的法人治理结构，并分 别设立了研发、生产、销售、财务等内部经营管理部门。公司各职能部门能够按 照公司制订的管理制度，在管理层的领导下规范运作。公司已形成了与公司实际 情况相适应的、有效的经营运作模式，组织机构分工明确、职能健全清晰，与股 东不存在任何隶属关系。 公司设立监事会，代表全体股东监督董事会 ...

目 录 | | | 二、报告附件………………………………………………… 第 3—7 页 内部控制审计报告 天健审〔2025〕15-40 号 常州武进中瑞电子科技股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我 们审计了常州武进中瑞电子科技股份有限公司（以下简称中瑞股份公司）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》《企业内部控制应用指引》以及《企业内部 控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是中瑞 股份公司董事会的责任。 天健会计师事务所（特殊普通合伙） 中国注册会计师： 中国·杭州 中国注册会计师： 二〇二五年四月二十三日 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表 审计意见，并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。此外，由于 情况的变化可能导致内部控制变得不恰当，或对控制政策和程序遵循的程度降低， 根据内部控制审计结果推测未来内 ...

华泰联合证券有限责任公司 关于常州武进中瑞电子科技股份有限公司 2024年度募集资金存放与使用情况专项核查报告 华泰联合证券有限责任公司（以下简称"华泰联合证券"）作为常州武进中 瑞电子科技股份有限公司（以下简称"中瑞股份"、"公司"）首次公开发行股 票的保荐人，根据《证券发行上市保荐业务管理办法》《上市公司监管指引第2 号——上市公司募集资金管理和使用的监管要求》《深圳证券交易所创业板股票 上市规则》及《深圳证券交易所上市公司自律监管指引第13号——保荐业务》等 法律法规的规定，对中瑞股份在2024年度募集资金存放与使用情况进行了核查， 核查情况如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会《关于同意常州武进中瑞电子科技股份有限公司 首次公开发行股票注册的批复》（证监许可〔2023〕2070 号），公司由主承销商 华泰联合证券有限责任公司采用向参与战略配售的投资者定向配售、网下向符合 条件的投资者询价配售及网上向持有深圳市场非限售 A 股股份和非限售存托凭 证市值的社会公众投资者定价发行相结合的方式，发行人民币普通股（A 股） 36,832,010 股，发行价为 ...

本鉴证报告仅供中瑞股份公司年度报告披露时使用，不得用作任何其他目的。 我们同意将本鉴证报告作为中瑞股份公司年度报告的必备文件，随同其他文件一 起报送并对外披露。 二、关于募集资金年度存放与使用情况的专项报告…………… 第 3—10 页 三、报告附件………………………………………………………第 11—15 页 募集资金年度存放与使用情况鉴证报告 天健审〔2025〕15-41 号 常州武进中瑞电子科技股份有限公司全体股东： 我们鉴证了后附的常州武进中瑞电子科技股份有限公司（以下简称中瑞股份 公司）管理层编制的 2024 年度《关于募集资金年度存放与使用情况的专项报告》。 一、对报告使用者和使用目的的限定 目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 二、管理层的责任 中瑞股份公司管理层的责任是提供真实、合法、完整的相关资料，按照《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年 修订）》（证监会公告〔2022〕15 号）和《深圳证券交易所上市公司自律监管 指引第 2 号——创业板上市公司规范运作（2023 年 12 月修订）》（深证上〔2023〕 ...

Financial Performance - The company's operating revenue for 2024 was ¥636,497,196.06, a decrease of 7.33% compared to ¥686,852,801.96 in 2023[18]. - Net profit attributable to shareholders for 2024 was ¥75,077,967.58, down 44.78% from ¥135,966,185.15 in 2023[18]. - The net profit after deducting non-recurring gains and losses was ¥64,547,419.38, a decline of 48.79% from ¥126,033,460.03 in 2023[18]. - Cash flow from operating activities showed a significant drop to ¥51,128,954.61, down 80.82% from ¥266,577,539.10 in 2023[18]. - Basic and diluted earnings per share decreased to ¥0.54, down 56.10% from ¥1.23 in 2023[18]. - Total assets increased to ¥2,465,890,211.24 at the end of 2024, a growth of 56.14% compared to ¥1,579,268,558.01 at the end of 2023[18]. - Net assets attributable to shareholders rose to ¥2,022,999,298.80, reflecting a 64.96% increase from ¥1,226,339,575.79 in 2023[18]. - The company achieved a revenue of 636.4972 million yuan, a decrease of 7.33% compared to the same period last year[46]. - The net profit attributable to shareholders was 75.078 million yuan, down 44.78% year-on-year[46]. Dividend Policy - The company plans to distribute a cash dividend of 3.5 RMB per 10 shares to all shareholders, based on a total of 147,328,040 shares[5]. - The total distributable profit for the year is 631,058,554.75 yuan, with the cash dividend accounting for 100% of the profit distribution[167]. - The company does not plan to issue bonus shares or increase capital from the capital reserve in the current profit distribution proposal[167]. - The company’s cash dividend policy is consistent with its articles of association and shareholder resolutions[165]. - The company plans to distribute at least 30% of the average distributable profit over three years in cash, provided there are no major investment plans or significant cash payments[191]. Market Position and Industry Outlook - The company operates in the metal products industry, focusing on the R&D, manufacturing, and sales of precision safety components for cylindrical lithium batteries, primarily for the electric vehicle and energy storage sectors[28]. - In 2024, China's new energy passenger vehicle sales are projected to reach 11.05 million units, a year-on-year increase of 40.2%, with a penetration rate of 48.9%[30]. - The installed capacity of power batteries for new energy vehicles in China is expected to be approximately 531 GWh in 2024, representing a year-on-year growth of 47.6%[30]. - Global energy storage battery shipments are forecasted to reach 369.8 GWh in 2024, with a year-on-year increase of 64.9%, and Chinese companies accounting for 93.5% of this total[31]. - The global market for precision structural components in lithium batteries is anticipated to grow alongside the increasing demand from the new energy vehicle and energy storage sectors[34]. Research and Development - The company invested CNY 55.78 million in R&D during the reporting period, accounting for 8.76% of operating revenue, focusing on product safety, reliability, and lightweight design[59]. - The company holds 92 authorized patents, including 13 invention patents and 79 utility model patents, showcasing its strong R&D capabilities[48]. - The company is actively engaged in the research and development of lithium battery structural components, aligning with the trends in cylindrical battery development and customer product solutions[40]. - The company aims to enhance its technological capabilities and product quality while reducing production costs in response to industry regulations and standards[39]. Risk Management - The report emphasizes the importance of risk awareness regarding future plans and forecasts, indicating potential operational risks and corresponding countermeasures[5]. - The company faces risks from changes in industrial policies, particularly as the market shifts from policy-driven to market-driven, which may impact product sales and operational performance[103]. - The company is exposed to risks from fluctuations in raw material prices, which could increase production costs and affect gross margins despite efforts to optimize production processes[104]. - The company has a high customer concentration risk, as a significant portion of revenue comes from a few key clients, making it vulnerable to changes in their purchasing behavior[106]. Governance and Compliance - The company has established a governance structure that complies with relevant laws and regulations, ensuring the protection of shareholder rights[116]. - The company has a board of directors consisting of 5 members, including 2 independent directors, ensuring compliance with legal and regulatory requirements[119]. - The company adheres to strict information disclosure practices, ensuring timely and accurate communication with stakeholders through multiple channels[121]. - The company has implemented a value management system to enhance its market valuation[114]. Employee and Social Responsibility - The company emphasizes employee rights and has established a competitive benefits system to enhance employee satisfaction and safety[178]. - The company has a structured approach to environmental management, including waste disposal and compliance with relevant regulations[179]. - The company emphasizes the balance between economic and social benefits, actively fulfilling its social responsibilities[176]. Future Development Plans - The company aims to enhance its market position in the precision safety components for lithium batteries by increasing production scale and diversifying product categories[98]. - The company plans to establish a U.S. office as discussed in the 15th board meeting on March 18, 2024[150]. - The company is committed to maintaining high standards of quality and compliance, as reflected in the roles of its quality management personnel[142][143].

Financial Performance - The company's revenue for Q1 2025 was ¥139,964,463.50, a decrease of 16.96% compared to ¥168,557,585.89 in the same period last year[5] - Net profit attributable to shareholders was ¥7,522,679.85, down 73.82% from ¥28,738,001.79 year-on-year[5] - Basic and diluted earnings per share decreased by 80.77% to ¥0.05 from ¥0.26 in the same period last year[5] - Net profit for the period was ¥7,206,198.31, down from ¥28,738,001.79, indicating a decline of approximately 75% year-over-year[22] - The company reported a total comprehensive income of ¥3,491,846.44, down from ¥28,738,001.79, indicating a significant decrease[23] Cash Flow - The net cash flow from operating activities was -¥19,381,344.29, representing an 11.82% decline compared to -¥17,332,334.43 in the previous year[5] - Cash inflow from operating activities rose to ¥128,262,586.13 from ¥117,569,960.89, an increase of approximately 9% year-over-year[25] - The net cash flow from operating activities was -$19,381,344.29, compared to -$17,332,334.43 in the previous period, indicating a decline in operational cash generation[26] - The total cash and cash equivalents at the end of the period stood at $49,689,943.99, down from $751,705,190.21, showing a significant reduction in liquidity[26] - The net cash flow from investment activities was -$54,831,577.28, worsening from -$22,863,455.66 previously, suggesting higher cash outflows for investments[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,446,242,773.26, a slight decrease of 0.80% from ¥2,465,890,211.24 at the end of the previous year[5] - Total current assets decreased from CNY 1,206,619,576.04 to CNY 1,149,575,141.32, a decline of approximately 4.7%[18] - Total liabilities decreased to ¥401,757,911.47 from ¥430,024,752.85, a reduction of about 6.6% year-over-year[20] - Total current liabilities decreased from CNY 323,999,096.98 to CNY 295,859,604.58, a reduction of about 8.7%[19] Expenses - Management expenses rose by 45.40% to ¥14,855,411.93, primarily due to the establishment of a subsidiary in August 2024 and increased salaries[8] - Research and development expenses increased to ¥14,938,672.96 from ¥12,147,897.14, reflecting a growth of about 23% year-over-year[22] - Cash paid to employees was $45,830,038.05, an increase from $39,886,441.10, reflecting higher personnel costs[26] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,093, with the largest shareholder holding 50.14% of the shares[10] - The company reported a total of 3,522,710 shares held by Changzhou Ruijin Venture Capital Partnership (Limited Partnership), representing 2.39% of total shares[11] - The company has a total of 73,875,000 restricted shares held by Yang Xuexin, with a release date set for April 8, 2027[14] Investment Income - The company reported a significant increase in investment income, rising 1575.79% to ¥1,168,009.64 from a loss of ¥79,144.84 in the previous year[8] - Total cash inflow from investment activities was $299,025,602.34, significantly higher than $75,701,416.25 in the prior period, reflecting increased investment recovery[26] Taxation - The company experienced a 42.72% increase in taxes and surcharges, totaling ¥1,471,187.71 compared to ¥1,030,796.17 last year[8] - Cash paid for taxes was $5,760,585.07, down from $8,023,078.98, indicating a decrease in tax liabilities[26] Current Assets and Liabilities - Accounts receivable increased from CNY 136,613,322.25 to CNY 151,253,775.19, an increase of approximately 10.7%[18] - Inventory increased from CNY 118,438,089.00 to CNY 137,039,631.92, reflecting a growth of about 15.7%[18] - Accounts payable increased from CNY 96,024,608.87 to CNY 110,739,375.96, an increase of approximately 15.3%[19]